Consorteum Holdings, Inc. (CSRH) Offering Security,

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
393
Consorteum Holdings, Inc. (CSRH) Offering Security, Flexibility and Connectivity

- Developing technology that can deliver and manage complex, digitally secure transactions while serving a broad range of vertical markets in the fintech space
- Set to release 359’s first sports predictive analytics product dedicated to the popular global sport of cricket in the second quarter of 2018
- Leveraging industry expertise in the mobile app market, including the online and mobile gaming industry

Consorteum Holdings, Inc. (OTC: CSRH) is a software development and mobile platform company focused on delivering compliant complex mobile-based transactions. 359 Mobile Inc., a wholly owned subsidiary of CSRH, is developing end-to-end fintech solutions for various markets. Over the last eight years, 359 has developed the Universal Mobile Interface™ (UMI). This technology can deliver and manage complex, digitally secure transactions servicing a broad range of vertical markets in the fintech space. The UMI is unique and flexible for each individual client.

A joint business agreement between 359 and DevLex Ltd. is set to facilitate the release of 359’s first mobile sports predictive analytics platform (DV-PA). The first launch will be focused on the estimated 2.5 billion global cricket fans. The Cricket DV-PA is expected to be available on Google Play and the App Store for both Android and iOS devices in the second quarter of 2018. The Cricket DV-PA is a unique app offering predictive analysis built upon historical data and relevant updated cricket team and player statistics.

CSRH is developing its software and mobile publishing resources, and it is working to build partnerships and licensing agreements for a variety of mobile offerings – including those within the online and mobile gaming industry. With an estimated 164 million people worldwide using mobile devices for online gambling, there is a great need for secure connectivity and content. With worldwide consumer commitment to mobile app stores predicted to exceed $110 billion by the end of 2018 (http://nnw.fm/iiJK7), CSRH is working to leverage its expertise across this growing market.

For more information, visit the company’s website at www.Consorteum.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Consorteum Holdings (CSRH) Stock Research Links

CSRH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oscar Health Options Activity and Market Insights for Investors

Updated Category News Views 265

Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...

Continue Reading
Better Choice Company Finalizes Sale of Halo Asia Business

Updated Category News Views 160

Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....

Continue Reading
Fastenal Prepares for Earnings Report: What Investors Should Know

Updated Category News Views 154

Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....

Continue Reading
Compass Therapeutics Takes Major Steps in Biliary Cancer Trials

Updated Category News Views 203

Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...

Continue Reading
Understanding the Recent ECB Fine on LHV Group and Its Implications

Updated Category News Views 218

Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...

Continue Reading